DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Votrient (Pazopanib Hydrochloride) - Current Clinical Trials

 
 



Votrient Related Clinical Trials

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer [Recruiting]

A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma [Recruiting]

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer [Active, not recruiting]

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma [Recruiting]

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer [Recruiting]

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK [Completed]

Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible [Recruiting]

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Terminated]

Pazopanib Tolerability When Given With Food [Recruiting]

Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors [Recruiting]

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients [Active, not recruiting]

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 [Completed]

Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - [Recruiting]

Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors [Completed]

Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma [Recruiting]

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma [Recruiting]

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) [Completed]

Treatment of Corneal Neovascularization With Topical Pazopanib [Completed]

Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment [Completed]

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) [Active, not recruiting]

Pazopanib, Docetaxel, Prednisone Prostate [Active, not recruiting]

Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma [Recruiting]

Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors [Not yet recruiting]

Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma [Terminated]

Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma [Recruiting]

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) [Active, not recruiting]

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer [Completed]

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer [Completed]

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer [Completed]

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [Not yet recruiting]

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer [Completed]

Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid and CNS Tumours [Recruiting]

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors [Recruiting]

PAZOPANIB Efficacy and Tolerance in Desmoids Tumors [Recruiting]

Pazopanib in Second-line Therapy in Renal Cell Carcinoma [Active, not recruiting]

Pazopanib Maintenance Phase II [Recruiting]

Pazopanib in Molecularly Selected Patients With Advanced NSCLC [Recruiting]

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) [Recruiting]

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors [Completed]

Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria [Recruiting]

Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer [Active, not recruiting]

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Completed]

Study To Assess Long Term Safety Of Pazopanib [Active, not recruiting]

Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma [Recruiting]

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer [Active, not recruiting]

Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery [Terminated]

A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers [Completed]

Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma [Completed]

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma [Terminated]

VEG111485: A QTc Study of Pazopanib [Completed]

Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer [Completed]

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer [Completed]

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Recruiting]

Phase I Study of Pazopanib and Vorinostat [Recruiting]

Neoadjuvant Pazopanib in Renal Cell Carcinoma [Recruiting]

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD [Completed]

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Active, not recruiting]

Pazopanib Maintenance for SCLC [Recruiting]

HYPAZ: Hypertension Induced by Pazopanib [Terminated]

Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) [Not yet recruiting]

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme [Recruiting]

Rotating Pazopanib and Everolimus to Avoid Resistance [Completed]

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder [Completed]

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Recruiting]

Treatment With Pazopanib for Neoadjuvant Breast Cancer [Completed]

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Completed]

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors [Completed]

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Recruiting]

Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Suspended]

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma [Completed]

A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes [Completed]

Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung [Recruiting]

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer [Active, not recruiting]

Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) [Recruiting]

Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma [Recruiting]

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II) [Recruiting]

Phase II Study of Pazopanib and Topotecan in Cervical Cancer [Not yet recruiting]

Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer [Not yet recruiting]

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery [Active, not recruiting]

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma [Recruiting]

A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors [Completed]

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Recruiting]

A Study of Pazopanib With CAPEOX in AGC Patients [Recruiting]

Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops [Completed]

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma [Active, not recruiting]

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors [Completed]

Hepatic Monitoring for Pazopanib [Completed]

Pazopanib in Treating Patients With Recurrent Glioblastoma [Completed]

Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma [Recruiting]

Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017